Tracey Jubelirer, MD, is the Medical Director of the inpatient oncology unit at the Middleman Family Pavilion at Children’s Hospital of Philadelphia, King of Prussia.

CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.

Method measures motor imitation skills, which have been challenging to measure consistently and precisely.

As part of a longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s Hospital of Philadelphia (CHOP)will exhibit leading medical breakthroughs in the EHS booth at the annual Arab Health Exhibition and Congress, which is taking place at the Dubai International Convention and Exhibition Centre this week.

The Middleman Family Pavilion, including 24/7 Emergency Department, will give more families easier access to CHOP’s best-in-class pediatric specialists.

While spinal fusion remains the gold standard to treat adolescent idiopathic scoliosis, CHOP continues to explore new – and less invasive – treatments.

New test analyzes mitochondrial DNA to find and quantify certain variations and deletions, providing a useful diagnostic tool that helps guide treatment.

The Asmund Laerdal Foundation and RQI Partners LLC’s Philanthropic Support Will Advance Best Pediatric Cardiac Arrest Prevention, Preparation, Education, and Resuscitation Practices.

CHOP researchers found that levels of proteins in the plasma of patients with MIS-C are significantly dysregulated and share features with two other inflammatory syndromes.

Children with high-functioning autism can be an easy target for bullies. A CHOP pediatrician offers tips to help parents address bullying behavior and teach coping skills.